Glycosylated Hemoglobin Is a Predictor of Major Adverse Cardiac Events after Drug-Eluting Stent Implantation in Patients with Diabetes Mellitus

Publisher： Karger

E-ISSN： 1421-9751|116|1|51-57

ISSN： 0008-6312

Source： Cardiology, Vol.116, Iss.1, 2010-05, pp. : 51-57

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Assessment of Characteristics of Neointimal Hyperplasia after Drug-Eluting Stent Implantation in Patients with Diabetes Mellitus: An Optical Coherence Tomography Analysis

By  

Cardiology, Vol. 128, Iss. 1, 2014-02 ,pp. : 34-40

Karger

Access to resources Recommend Favorite

Periprocedural myocardial infarction is associated with increased mortality in patients with coronary artery bifurcation lesions after implantation of a drug‐eluting stent

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. S1, 2015-03 ,pp. : 696-705

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and efficacy of policosanol in patients with high on‐treatment platelet reactivity after drug‐eluting stent implantation: two‐year follow‐up results

By  

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol. 34, Iss. 5, 2016-10 ,pp. : 337-342

John Wiley & Sons Inc

Access to resources Recommend Favorite

“Full Metal Jacket” Drug‐Eluting Stent Implantation

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 84, Iss. 7, 2014-12 ,pp. : 1051-1052

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence of adverse cardiac events 5 years after polymer‐free sirolimus eluting stent implantation: Results from the prospective Bad Berka Yukon Choice™ registry

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 84, Iss. 7, 2014-12 ,pp. : 1080-1086

John Wiley & Sons Inc

Access to resources Recommend Favorite